ReportsandReports - Pricing & Reimbursement in Emerging Markets: Analysis of Pricing Mechanisms and the Influence of Public and Private Sector Health Insurance Provision
Over the past few years, pharmaceutical sales in the emerging markets have regularly been growing at double-digit rates, albeit in some of the markets there has been a temporary blip caused by the global credit crunch. Much of the recent growth has been fuelled by an expansion in public sector health insurance coverage, which means that drug reimbursement is much more widespread than in the past. However, the growth of reimbursement systems, combined with the ongoing global economic difficulties, has...
View full press release